Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B

Dig Dis Sci. 2005 Oct;50(10):1791-2. doi: 10.1007/s10620-005-2939-4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • Cytokines / blood*
  • Follow-Up Studies
  • Hepatitis B e Antigens / blood*
  • Hepatitis B virus / genetics*
  • Hepatitis B, Chronic / blood*
  • Hepatitis B, Chronic / drug therapy
  • Humans
  • Interferon-alpha / therapeutic use
  • Mutation / genetics*
  • Promoter Regions, Genetic / genetics*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Cytokines
  • Hepatitis B e Antigens
  • Interferon-alpha